Role of blood-brain barrier in cerebral malaria

The Blood-Brain Barrier: New Research

Volumn , Issue , 2012, Pages 287-312

  Prato, Mauro ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Blood brain barrier (BBB); Cerebral malaria; Cytokines; Matrix metalloproteinases (MMPs); Plasmodium falciparum; Tight junctions

Indexed keywords

EID: 84895205797     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (156)

1. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol. Dis. 2010;37:13-25
2. Adams S, Brown H, Turner G. Breaking down the blood-brain barrier: signaling a path to cerebral malaria? Trends Parasitol. 2002;18:360-6
3. Andolfo A, English WR, Resnati M, Murphy G, Blasi F, Sidenius N. Metalloproteases cleave the urokinase-type plasminogen activator receptor in the D1-D2 linker region and expose epitopes not present in the intact soluble receptor. Thromb. Haemost. 2002;88:298-306
4. Angus BJ, Thanikkul K, Silamut K, White NJ, Udomsangpetch R. Short report: Rosette formation in Plasmodium ovale infection. Am. J. Trop. Med. Hyg. 1996;55:560-1
5. Armah HB, Wilson NO, Sarfo BY, Powell MD, Bond VC, Anderson W, Adjei AA, Gyasi RK, Tettey Y, Wiredu EK, Tongren JE, Udhayakumar V, Stiles JK. Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malar. J. 2007;6:147.
6. Asahi M, Wang X, Mori T, Sumii T, Jung JC, Moskowitz MA, Fini ME, Lo EH. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 2001;21:7724-32
7. Badibanga B, Dayal R, Depierreux M, Pidival G, Lambert PH. Principle immunological factors and the blood-brain barrier in cerebral malaria in children in endemic countries (Zaïre). Ann. Soc. Belg. Med. Trop. 1986;66:23-37
8. Beghdadi W, Porcherie A, Schneider BS, Dubayle D, Peronet R, Huerre M, Watanabe T, Ohtsu H, Louis J, Mécheri S. Inhibition of histamine-mediated signaling confers significant protection against severe malaria in mouse models of disease. J. Exp. Med. 2008;205:395-408
9. Beghdadi W, Porcherie A, Schneider BS, Morisset S, Dubayle D, Peronet R, Dy M, Louis J, Arrang JM, Mécheri S. Histamine H(3) receptor-mediated signaling protects mice from cerebral malaria. PLoS One. 2009;4:e6004
10. Blanco YC, Farias AS, Goelnitz U, Lopes SC, Arrais-Silva WW, Carvalho BO, Amino R, Wunderlich G, Santos LM, Giorgio S, Costa FT. Hyperbaric oxygen prevents early death caused by experimental cerebral malaria. PLoS One. 2008;3:e3126
11. Brown H, Hien TT, Day N, Mai NT, Chuong LV, Chau TT, Loc PP, Phu NH, Bethell D, Farrar J, Gatter K, White N, Turner G. Evidence of blood-brain barrier dysfunction in human cerebral malaria. Neuropathol. Appl. Neurobiol. 1999;25:331-40
12. Brown HC, Chau TT, Mai NT, Day NP, Sinh DX, White NJ, Hien TT, Farrar J, Turner GD. Blood-brain barrier function in cerebral malaria and CNS infections in Vietnam. Neurology. 2000;55:104-11
13. Brown H, Rogerson S, Taylor T, Tembo M, Mwenechanya J, Molyneux M, Turner G. Blood-brain barrier function in cerebral malaria in Malawian children. Am. J. Trop. Med Hyg. 2001;64:207-13
14. Carney CK, Schrimpe AC, Halfpenny K, Harry RS, Miller CM, Broncel M, Sewell SL, Schaff JE, Deol R, Carter MD, Wright DW. The basis of the immunomodulatory activity of malaria pigment (hemozoin). J. Biol. Inorg. Chem. 2006;11:917-29
15. Carter JA, Neville BG, Newton CR. Neuro-cognitive impairment following acquired central nervous system infections in childhood: a systematic review. Brain Res. Brain Res. Rev. 2003;43:57-69
16. Carter JA, Neville BG, White S, Ross AJ, Otieno G, Mturi N, Musumba C, Newton CR. Increased prevalence of epilepsy associated with severe falciparum malaria in children. Epilepsia. 2004;45:978-81
17. Cauwe B, Van den Steen PE, Opdenakker G. The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit. Rev. Biochem. Mol. Biol. 2007 May-Jun;42(3):113-85
18. Chakravorty SJ, Craig A. The role of ICAM-1 in Plasmodium falciparum cytoadherence. Eur. J. Cell Biol. 2005;84:15-27
19. Chotivanich KT, Pukrittayakamee S, Simpson JA, White NJ, Udomsangpetch R. Characteristics of Plasmodium vivax-infected erythrocyte rosettes. Am. J. Trop. Med. Hyg. 1998;59:73-6
20. Clark IA, Virelizier JL, Carswell EA, Wood PR. Possible importance of macrophage-derived mediators in acute malaria. Infect. Immun. 1981;32:1058-66
21. Clark IA, Cowden WB. The pathophysiology of falciparum malaria. Pharmacol Ther. 2003;99:221-60.
22. Clark IA, Budd AC, Alleva LM, Cowden WB. Human malarial disease: a consequence of inflammatory cytokine release. Malar. J. 2006;5:85
23. Clark IA, Alleva LM, Budd AC, Cowden WB. Understanding the role of inflammatory cytokines in malaria and related diseases. Travel Med. Infect. Dis. 2008;6:67-81
24. Coltel N, Combes V, Hunt NH, Grau GE. Cerebral malaria -- a neurovascular pathology with many riddles still to be solved. Curr. Neurovasc. Res. 2004;1:91-110
25. Combes V, Coltel N, Faille D, Wassmer SC, Grau GE. Cerebral malaria: role of microparticles and platelets in alterations of the blood-brain barrier. Int. J. Parasitol. 2006;36:541-6
26. Combes V, El-Assaad F, Faille D, Jambou R, Hunt NH, Grau GE. Microvesiculation and cell interactions at the brain-endothelial interface in cerebral malaria pathogenesis. Prog. Neurobiol. 2010;91:140-51
27. Covington MD, Burghardt RC, Parrish AR. Ischemia-induced cleavage of cadherins in NRK cells requires MT1-MMP (MMP-14). Am. J. Physiol. Renal. Physiol. 2006;290:F43-51
28. Cucullo L, Aumayr B, Rapp E, Janigro D. Drug delivery and in vitro models of the blood-brain barrier. Curr. Opin. Drug Discov. Devel. 2005;8:89-99
29. Cucullo L, Couraud PO, Weksler B, Romero IA, Hossain M, Rapp E, Janigro D. Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies. J. Cereb. Blood Flow Metab. 2008;28:312-28
30. Das BS, Mohanty S, Mishra SK, Patnaik JK, Satpathy SK, Mohanty D, Bose TK. Increased cerebrospinal fluid protein and lipid peroxidation products in patients with cerebral malaria. Trans. R. Soc. Trop. Med. Hyg. 1991;85:733-4
31. Das BS, Patnaik JK, Mohanty S, Mishra SK, Mohanty D, Satpathy SK, Bose TK. Plasma antioxidants and lipid peroxidation products in falciparum malaria. Am. J. Trop. Med. Hyg. 1993;49:720-5
32. David PH, Hommel M, Miller LH, Udeinya IJ, Oligino LD. Parasite sequestration in Plasmodium falciparum malaria: spleen and antibody modulation of cytoadherence of infected erythrocytes. Proc. Natl. Acad. Sci. USA. 1983;80:5075-9
33. De Boer AB, De Lange EL, Van der Sandt IC, Breimer DD. Transporters and the blood-brain barrier (BBB). Int J Clin Pharmacol Ther. 1998;36:14-5
34. de Souza JB, Hafalla JC, Riley EM, Couper KN. Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease. Parasitology. 2010;137:755-72
35. Deininger MH, Fimmen B, Kremsner PG, Meyermann R, Schluesener HJ. Accumulation of endostatin/collagenXVIII in brains of patients who died with cerebral malaria. J. Neuroimmunol. 2002;131:216-21
36. Deininger MH, Winkler S, Kremsner PG, Meyermann R, Schluesener HJ. Angiogenic proteins in brains of patients who died with cerebral malaria. J. Neuroimmunol. 2003;142:101-11
37. Dell'agli M, Galli GV, Bulgari M, Basilico N, Romeo S, Bhattacharya D, Taramelli D, Bosisio E. Ellagitannins of the fruit rind of pomegranate (Punica granatum) antagonize in vitro the host inflammatory response mechanisms involved in the onset of malaria. Malar. J. 2010;9:208
38. Dietmann A, Helbok R, Lackner P, Issifou S, Lell B, Matsiegui PB, Reindl M, Schmutzhard E, Kremsner PG. Matrix metalloproteinases and their tissue inhibitors (TIMPs) in Plasmodium falciparum malaria: serum levels of TIMP-1 are associated with disease severity. J. Infect. Dis. 2008;197:1614-20.
39. Doeuvre L, Plawinski L, Toti F, Anglés-Cano E. Cell-derived microparticles: a new challenge in neuroscience. J. Neurochem. 2009;110:457-68
40. Dondorp AM, Angus BJ, Hardeman MR, Chotivanich KT, Silamut K, Ruangveerayuth R, Kager PA, White NJ, Vreeken J. Prognostic significance of reduced red blood cell deformability in severe falciparum malaria. Am. J. Trop. Med. Hyg. 1997;57:507-11
41. Dondorp AM, Angus BJ, Chotivanich K, Silamut K, Ruangveerayuth R, Hardeman MR, Kager PA, Vreeken J, White NJ. Red blood cell deformability as a predictor of anemia in severe falciparum malaria. Am. J. Trop. Med. Hyg. 1999;60:733-7
42. Dorovini-Zis K, Schmidt K, Huynh H, Fu W, Whitten RO, Milner D, Kamiza S, Molyneux M, Taylor TE. The neuropathology of fatal cerebral malaria in Malawian children. Am. J. Pathol. 2011;178:2146-58
43. Egan TJ. Recent advances in understanding the mechanism of hemozoin (malaria pigment) formation. J. Inorg. Biochem. 2008;102:1288-99
44. Emmi A, Wenzel HJ, Schwartzkroin PA, Taglialatela M, Castaldo P, Bianchi L, Nerbonne J, Robertson GA, Janigro D. Do glia have heart? Expression and functional role for ether-a-go-go currents in hippocampal astrocytes. J. Neurosci. 2000;20:3915-25
45. Faille D, El-Assaad F, Alessi MC, Fusai T, Combes V, Grau GE. Platelet-endothelial cell interactions in cerebral malaria: the end of a cordial understanding. Thromb. Haemost. 2009;102:1093-102
46. Fauser S, Deininger MH, Kremsner PG, Magdolen V, Luther T, Meyermann R, Schluesener HJ. Lesion associated expression of urokinase-type plasminogen activator receptor (uPAR, CD87) in human cerebral malaria. J. Neuroimmunol. 2000;111:234-40
47. Fiore E, Fusco C, Romero P, Stamenkovic I. Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity. Oncogene. 2002;21:5213-23
48. Franklin BS, Ishizaka ST, Lamphier M, Gusovsky F, Hansen H, Rose J, Zheng W, Ataíde MA, de Oliveira RB, Golenbock DT, Gazzinelli RT. Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria. Proc. Natl. Acad. Sci. USA. 2011;108:3689-94
49. Gearing AJ, Beckett P, Christodoulou M, Churchill M, Clements JM, Crimmin M, Davidson AH, Drummond AH, Galloway WA, Gilbert R, et al. Matrix metalloproteinases and processing of pro-TNF-alpha. J. Leukoc. Biol. 1995;57:774-7
50. Geurts N, Martens E, Van Aelst I, Proost P, Opdenakker G, Van den Steen PE. Beta-hematin interaction with the hemopexin domain of gelatinase B/MMP-9 provokes autocatalytic processing of the propeptide, thereby priming activation by MMP-3. Biochemistry. 2008;47:2689-99
51. Giebel SJ, Menicucci G, McGuire PG, Das A. Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier. Lab. Invest. 2005;85:597-607
52. Gimenez F, Barraud de Lagerie S, Fernandez C, Pino P, Mazier D. Tumor necrosis factor alpha in the pathogenesis of cerebral malaria. Cell Mol. Life Sci. 2003;60:1623-35
53. Giribaldi G, Prato M, Ulliers D, Gallo V, Schwarzer E, Akide-Ndunge OB, Valente E, Saviozzi S, Calogero RA, Arese P. Involvement of inflammatory chemokines in survival of human monocytes fed with malarial pigment. Infect. Immun. 2010;78:4912-21.
54. Giribaldi, Valente E, Khadjavi A, Polimeni M, Prato M. Macrophage Inflammatory Protein-1alpha mediates Matrix Metalloproteinase-9 enhancement in human adherent monocytes fed with malarial pigment. Asian Pac. J. Trop. Med. 2011;in press
55. Gitau EN, Newton CR. Review Article: blood-brain barrier in falciparum malaria. Trop Med Int Health. 2005;10:285-92
56. Gorodeski GI. Estrogen decrease in tight junctional resistance involves matrix-metalloproteinase-7-mediated remodeling of occludin. Endocrinology. 2007;148:218-31
57. Griffiths MJ, Shafi MJ, Popper SJ, Hemingway CA, Kortok MM, Wathen A, Rockett KA, Mott R, Levin M, Newton CR, Marsh K, Relman DA, Kwiatkowski DP. Genomewide analysis of the host response to malaria in Kenyan children. J. Infect. Dis. 2005;191:1599-611
58. Green JA, Thi Hong Chau T, Farrar JJ, Friedland JS, Thwaites GE. CNS infection, CSF matrix metalloproteinase concentrations, and clinical/laboratory features. Neurology. 201176:577-579
59. Gurney KJ, Estrada EY, Rosenberg GA. Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation. Neurobiol. Dis. 2006;23:87-96
60. Hagenbuch B, Gao B, Meier PJ. Transport of xenobiotics across the blood-brain barrier. News Physiol. Sci. 2002;17:231-4
61. Hansen AM, Driussi C, Turner V, Takikawa O, Hunt NH. Tissue distribution of indoleamine 2,3-dioxygenase in normal and malaria-infected tissue. Redox Rep. 2000;5:112-5
62. Hensmann M, Kwiatkowski D. Cellular basis of early cytokine response to Plasmodium falciparum. Infect. Immun. 2001;69:2364-71
63. Herbas MS, Ueta YY, Ichikawa C, Chiba M, Ishibashi K, Shichiri M, Fukumoto S, Yokoyama N, Takeya M, Xuan X, Arai H, Suzuki H. Alpha-tocopherol transfer protein disruption confers resistance to malarial infection in mice. Malar. J. 2010a;9:101
64. Herbas MS, Okazaki M, Terao E, Xuan X, Arai H, Suzuki H. alpha-Tocopherol transfer protein inhibition is effective in the prevention of cerebral malaria in mice. Am. J. Clin. Nutr. 2010b;91:200-7
65. Ichikawa Y, Ishikawa T, Momiyama N, Kamiyama M, Sakurada H, Matsuyama R, Hasegawa S, Chishima T, Hamaguchi Y, Fujii S, Saito S, Kubota K, Hasegawa S, Ike H, Oki S, Shimada H. Matrilysin (MMP-7) degrades VE-cadherin and accelerates accumulation of beta-catenin in the nucleus of human umbilical vein endothelial cells. Oncol. Rep. 2006;15:311-5
66. Ichiyasu H, McCormack JM, McCarthy KM, Dombkowski D, Preffer FI, Schneeberger EE. Matrix metalloproteinase-9-deficient dendritic cells have impaired migration through tracheal epithelial tight junctions. Am. J. Respir. Cell Mol. Biol. 2004;30:761-70
67. Ito A, Mukaiyama A, Itoh Y, Nagase H, Thogersen IB, Enghild JJ, Sasaguri Y, Mori Y. Degradation of interleukin 1beta by matrix metalloproteinases. J. Biol. Chem. 1996 21;271:14657-60
68. Jacobs P, Radzioch D, Stevenson MM. A Th1-associated increase in tumor necrosis factor alpha expression in the spleen correlates with resistance to blood-stage malaria in mice. Infect. Immun. 1996;64:535-41
69. Jung K. Measurement of matrix metalloproteinases and their tissue inhibitors in serum produces doubtful results. J. Infect. Dis. 2008;198:1722-3
70. Khadjavi A, Giribaldi G, Prato M. From control to eradication of malaria: the end of being stuck in second gear? Asian Pac. J. Trop. Med. 2010;3:412-420.
71. Kwiatkowski D. Tumour necrosis factor, fever and fatality in falciparum malaria. Immunol. Lett. 1990;25:213-6
72. Lacerda-Queiroz N, Lima OC, Carneiro CM, Vilela MC, Teixeira AL, Carvalho AT, Araújo MS, Martins-Filho OA, Braga EM, Carvalho-Tavares J. Plasmodium berghei NK65 induces cerebral leukocyte recruitment in vivo: An intravital microscopic study. Acta Trop. Epub. 2011 Jun 29
73. Lacout A, Guidoux C, Carlier RY. Posterior reversible encephalopathy syndrome in neuro-malaria. Indian J. Radiol. Imaging. 2010;20:198-201
74. Liberto CM, Albrecht PJ, Herx LM, Yong VW, Levison SW. Pro-regenerative properties of cytokine-activated astrocytes. J. Neurochem. 2004;89:1092-100
75. Lijnen HR. Elements of the fibrinolytic system. Ann. NY Acad. Sci. 2001; 936:226-36
76. Lijnen HR. Matrix metalloproteinases and cellular fibrinolytic activity. Biochemistry (Mosc). 2002;67:92-8
77. MacPherson GG, Warrell MJ, White NJ, Looareesuwan S, Warrell DA. Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am. J. Pathol. 1985;119:385-401
78. Maegraith B, Fletcher A. The pathogenesis of mammalian malaria. Adv. Parasitol. 1972;10:49-75
79. Medana IM, Turner GD. Human cerebral malaria and the blood-brain barrier. Int. J. Parasitol. 2006;36:5
80. Migasena P, Maegraith BG. The movement of radioactive albumin (I131 R.H.S.A.) from blood into C.S.F. and vice versa by dilution method in normal and Plasmodium knowlesi infected Macaca mulatta. Med. J. Malaya. 1968a;22:250
81. Migasena P, Maegraith BG. Factor affecting on the movement of protein across the blood: brain: C.S.F. barriers in Plasmodium knowlesi infected Macaca mulatta. Med. J. Malaya. 1968b;22:251
82. Migasena P, Maegraith BG. The movement of fluorescent isothiocyanate (F.I.T.C.) labelled human albumin from blood into brain tissue examined by fluorescent technique in normal and Plasmodium knowlesi infected Macaca mulatta. Med. J. Malaya. 1968c;22:251
83. Miller CM, Carney CK, Schrimpe AC, Wright DW. beta-Hematin (hemozoin) mediated decompostion of polyunsaturated fatty acids to 4-hydroxy-2-nonenal. Inorg. Chem. 2005;44:2134-6
84. Mohanty S, Patel DK, Pati SS, Mishra SK. Adjuvant therapy in cerebral malaria. Indian J. Med. Res. 2006;124:245-60
85. Monea S, Jordan BA, Srivastava S, DeSouza S, Ziff EB. Membrane localization of membrane type 5 matrix metalloproteinase by AMPA receptor binding protein and cleavage of cadherins. J. Neurosci. 2006;26:2300-12
86. Morrell CN, Srivastava K, Swaim A, Lee MT, Chen J, Nagineni C, Hooks JJ, Detrick B. Beta interferon suppresses the development of experimental cerebral malaria. Infect. Immun. 2011;79:1750-8
87. Mturi N, Keir G, Maclennan CA, Ross A, Willis AC, Elford BC, Berkley JA, Newton CR. Cerebrospinal Fluid Studies in Kenyan Children with Severe Falciparum Malaria. Open Trop. Med. J. 2008;1:56-62
88. Nagase H. Cell surface activation of progelatinase A (proMMP-2) and cell migration. Cell Res. 1998;8:179-86
89. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J. Biol. Chem. 1999;274:21491-4.
90. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006;69:562-73
91. Neill AL, Hunt NH. Pathology of fatal and resolving Plasmodium berghei cerebral malaria in mice. Parasitology. 1992;105:165-75
92. Neill AL, Hunt NH. Effects of endotoxin and dexamethasone on cerebral malaria in mice. Parasitology. 1995;111:443-54
93. Newton CR, Warrel DA. Neurological manifestations of falciparum malaria. Ann. Neurol. 1998;43:695-702
94. Nguyen TH, Day NP, Ly VC, Waller D, Mai NT, Bethell DB, Tran TH, White NJ. Post-malaria neurological syndrome. Lancet. 1996;348:917-21
95. Overall CM, Dean RA. Degradomics: systems biology of the protease web. Pleiotropic roles of MMPs in cancer. Cancer Metastasis Rev. 2006;25:69-75
96. Penet MF, Abou-Hamdan M, Coltel N, Cornille E, Grau GE, de Reggi M, Gharib B. Protection against cerebral malaria by the low-molecular-weight thiol pantethine. Proc. Natl. Acad. Sci. USA. 2008;105:1321-6
97. Perkins DJ, Weinberg JB, Kremsner PG. Reduced interleukin-12 and transforming growth factor-beta1 in severe childhood malaria: relationship of cytokine balance with disease severity. J. Infect. Dis. 2000;182:988-92
98. Piguet PF, Da Laperrousaz C, Vesin C, Tacchini-Cottier F, Senaldi G, Grau GE. Delayed mortality and attenuated thrombocytopenia associated with severe malaria in urokinase- and urokinase receptor-deficient mice. Infect. Immun. 2000;68:3822-9
99. Pino P, Taoufiq Z, Nitcheu J, Vouldoukis I, Mazier D. Blood-brain barrier breakdown during cerebral malaria: suicide or murder? Thromb. Haemost. 2005;94:336-40
100. Polder T, Jerusalem C, Eling W. Topographical distribution of the cerebral lesions in mice infected with Plasmodium berghei. Tropenmed Parasitol. 1983;34:235-43
101. Polder TW, Eling WM, Kubat K, Jerusalem CR. Histochemistry of cerebral lesions in mice infected with Plasmodium berghei. Trop. Med. Parasitol. 1988;39:277-83
102. Polder TW, Eling WM, Curfs JH, Jerusalem CR, Wijers-Rouw M. Ultrastructural changes in the blood-brain barrier of mice infected with Plasmodium berghei. Acta Leiden. 1992;60:31-46
103. Pongponratn E, Riganti M, Punpoowong B, Aikawa M. Microvascular sequestration of parasitized erythrocytes in human falciparum malaria: a pathological study. Am. J. Trop. Med. Hyg. 1991;44:168-75
104. Pongponratn E, Turner GD, Day NP, Phu NH, Simpson JA, Stepniewska K, Mai NT, Viriyavejakul P, Looareesuwan S, Hien TT, Ferguson DJ, White NJ. An ultrastructural study of the brain in fatal Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 2003;69:345-59
105. Prato M, Giribaldi G, Polimeni M, Gallo V, Arese P. Phagocytosis of hemozoin enhances matrix metalloproteinase-9 activity and TNF-alpha production in human monocytes: role of matrix metalloproteinases in the pathogenesis of falciparum malaria. J. Immunol. 2005;175:6436-42
106. Prato M, Gallo V, Giribaldi G, Arese P. Phagocytosis of haemozoin (malarial pigment) enhances metalloproteinase-9 activity in human adherent monocytes: role of IL-1beta and 15-HETE. Malar. J. 2008;7:157.
107. Prato M, Giribaldi G, Arese P. Hemozoin triggers tumor necrosis factor alpha-mediated release of lysozyme by human adherent monocytes: new evidences on leukocyte degranulation in P. falciparum malaria. Asian Pac. J. Trop. Med. 2009;2(3):35-40
108. Prato M, Gallo V, Giribaldi G, Aldieri E, Arese P. Role of the NF-κB transcription pathway in the haemozoin- and 15-HETE-mediated activation of matrix metalloproteinase-9 in human adherent monocytes. Cell Microbiol. 2010a;12:1780-91
109. Prato M, Gallo V, Arese P. Higher production of tumor necrosis factor alpha in hemozoin-fed human adherent monocytes is dependent on lipidic component of malarial pigment: new evidences on cytokine regulation in P. falciparum malaria. Asian Pac. J. Trop. Med. 2010b;3:85-89
110. Prato M, Gallo V, Valente E, Khadjavi A, Mandili G, Giribaldi G. Malarial pigment enhances Heat Shock Protein-27 in THP-1 cells: new perspectives for in vitro studies on monocyte apoptosis prevention. Asian Pac. J. Trop. Med. 2010c; 3: 934-38
111. Prato M, Giribaldi G. Matrix metalloproteinase-9 and haemozoin: wedding rings for human host and Plasmodium falciparum parasite in complicated malaria. J. Trop. Med. 2011a;2011:ID ID628435
112. Prato M, Valente E, Ulliers D, Khadjavi A, Giribaldi G. Quercetin, artemisinin and parthenolide abrogate the haemozoin- and 15-HETE-enhanced activity of enzymes released from gelatinase granules by human monocytes. Proceedings of the Antimal Conference - Antimalarial Drugs: Chemistry, Development and Future Challenges, London, UK, 15-16 March 2011. 2011b;P27:49
113. Prato M, D'Alessandro S, Van den Steen PE, Opdenakker G, Arese P, Taramelli D, Basilico N. Natural haemozoin modulates matrix metalloproteinases and induces morphological changes in human microvascular endothelium. Cell Microbiol. 2011c;13:1275-1285
114. Prato M, Khadjavi A, Mandili G, Minero VG, Giribaldi G. Insecticides as strategic weapons for malaria vector control. In: Insecticides/Book 3. Ed: InTech - Open Access Publisher. Rijeka, Croatia. ISBN: 979-953-307-667-5. 2011d;in press
115. Prato M. Involvement of matrix metalloproteinases in the malaria pathogenesis. In: Malaria: Etiology, Pathogenesis and Treatments. Ed: Nova Science Publishers, Inc. Hauppauge, NY, USA. ISBN: 978-1-62100-363-2. 2012;in press
116. Preece G, Murphy G, Ager A. Metalloproteinase-mediated regulation of L-selectin levels on leucocytes. J. Biol. Chem. 1996;271:11634
117. Ratnikov BI, Rozanov DV, Postnova TI, Baciu PG, Zhang H, DiScipio RG, Chestukhina GG, Smith JW, Deryugina EI, Strongin AY. An alternative processing of integrin alpha(v) subunit in tumor cells by membrane type-1 matrix metalloproteinase. J. Biol. Chem. 2002;277:7377-85
118. Rosenberg GA. Matrix metalloproteinases in neuroinflammation. Glia. 2002;39:279-91
119. Rosenberg GA, Yang Y. Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia. Neurosurg. Focus. 2007;22:E4
120. Sanni LA. The role of cerebral oedema in the pathogenesis of cerebral malaria. Redox Rep. 2001;6:137-42
121. Santos-Martínez MJ, Medina C, Jurasz P, Radomski MW. Role of metalloproteinases in platelet function. Thromb. Res. 2008;121:535-42
122. Schmidt KE, Schumak B, Specht S, Dubben B, Limmer A, Hoerauf A. Induction of pro-inflammatory mediators in Plasmodium berghei infected BALB/c mice breaks blood-brain-barrier and leads to cerebral malaria in an IL-12 dependent manner. Microbes Infect. 2011;13:828-36.
123. Schönbeck U, Mach F, Libby P. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J. Immunol. 1998;161:3340-6
124. Schrimpe AC, Wright DW. Comparative analysis of gene expression changes mediated by individual constituents of hemozoin. Chem. Res. Toxicol. 2009a;22:433-45
125. Schrimpe AC, Wright DW. Differential gene expression mediated by 15-hydroxyeicosatetraenoic acid in LPS-stimulated RAW 264.7 cells. Malar. J. 2009b;8:195
126. Schwarzer E, Ludwig P, Valente E, Arese P. 15(S)-hydroxyeicosatetraenoic acid (15-HETE), a product of arachidonic acid peroxidation, is an active component of hemozoin toxicity to monocytes. Parassitologia. 1999;41:199-202
127. Senanayake N, de Silva HJ. Delayed cerebellar ataxia complicating falciparum malaria: a clinical study of 74 patients. J. Neurol. 1994;241:456-9
128. Sherman IW, Eda S, Winograd E. Cytoadherence and sequestration in Plasmodium falciparum: defining the ties that bind. Microbes Infect. 2003;5:897-909
129. Sheu BC, Hsu SM, Ho HN, Lien HC, Huang SC, Lin RH. A novel role of metalloproteinase in cancer-mediated immunosuppression. Cancer Res. 2001;61:237-42
130. Silamut K, Phu NH, Whitty C, Turner GD, Louwrier K, Mai NT, Simpson JA, Hien TT, White NJ. A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain. Am. J. Pathol. 1999;155:395-410
131. Somerville RP, Oblander SA, Apte SS. Matrix metalloproteinases: old dogs with new tricks. Genome Biol. 2003;4:216
132. Steinhusen U, Weiske J, Badock V, Tauber R, Bommert K, Huber O. Cleavage and shedding of E-cadherin after induction of apoptosis. J. Biol. Chem. 2001;276:4972-80
133. Szklarczyk A, Stins M, Milward EA, Ryu H, Fitzsimmons C, Sullivan D, Conant K. Glial activation and matrix metalloproteinase release in cerebral malaria. J. Neurovirol. 2007;13:2-10
134. Thomson JG, Annecke S. Observations of the pathology of the central nervous system in malignant tertian malaria, with remarks on certain clinical phenomena. J. Trop. Med. Hyg. 1926;29:313-46
135. Treeratanapiboon L, Psathaki K, Wegener J, Looareesuwan S, Galla HJ, Udomsangpetch R. In vitro study of malaria parasite induced disruption of blood-brain barrier. Biochem. Biophys. Res. Commun. 2005;335:810-8
136. Tripathi AK, Sullivan DJ, Stins MF. Plasmodium falciparum-infected erythrocytes increase intercellular adhesion molecule 1 expression on brain endothelium through NF-kappaB. Infect. Immun. 2006;74:3262-70
137. Tripathi AK, Sullivan DJ, Stins MF. Plasmodium falciparum-infected erythrocytes decrease the integrity of human blood-brain barrier endothelial cell monolayers. J. Infect. Dis. 2007;195:942-50
138. Tripathi AK, Sha W, Shulaev V, Stins MF, Sullivan DJ Jr. Plasmodium falciparum-infected erythrocytes induce NF-kappaB regulated inflammatory pathways in human cerebral endothelium. Blood. 2009;114:4243-52
139. Thumwood CM, Hunt NH, Clark IA, Cowden WB. Breakdown of the blood-brain barrier in murine cerebral malaria. Parasitology. 1988;96:579-89.
140. Udeinya IJ, Schmidt JA, Aikawa M, Miller LH, Green I. Falciparum malaria-infected erythrocytes specifically bind to cultured human endothelial cells. Science. 1981;213:555-7
141. Udomsangpetch R, Webster HK, Pattanapanyasat K, Pitchayangkul S, Thaithong S. Cytoadherence characteristics of rosette-forming Plasmodium falciparum. Infect. Immun. 1992;60:4483-90
142. Van den Steen PE, Proost P, Wuyts A, Van Damme J, Opdenakker G. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood. 2000;96:2673-81
143. Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit. Rev. Biochem. Mol. Biol. 2002; 37:375-536
144. Van Den Steen PE, Wuyts A, Husson SJ, Proost P, Van Damme J, Opdenakker G; Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. Eur. J. Biochem. 2003a;270:3739-49
145. Van den Steen PE, Husson SJ, Proost P, Van Damme J, Opdenakker G. Carboxyterminal cleavage of the chemokines MIG and IP-10 by gelatinase B and neutrophil collagenase. Biochem. Biophys. Res. Commun. 2003b;310:889-96
146. Van den Steen PE, Van Aelst I, Starckx S, Maskos K, Opdenakker G, Pagenstecher A. Matrix metalloproteinases, tissue inhibitors of MMPs and TACE in experimental cerebral malaria. Lab. Invest. 2006;86:873-88
147. van der Heyde HC, Nolan J, Combes V, Gramaglia I, Grau GE. A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol. 2006;22:503-8
148. Van Wart HE, Birkedal-Hansen H. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. USA. 1990;87:5578-82
149. von Bredow DC, Nagle RB, Bowden GT, Cress AE. Cleavage of beta 4 integrin by matrilysin. Exp. Cell Res. 1997;236:341-5
150. Walker O, Salako LA, Sowunmi A, Thomas JO, Sodeine O, Bondi FS. Prognostic risk factors and post mortem findings in cerebral malaria in children. Trans. R. Soc. Trop. Med. Hyg. 1992;86:491-3
151. Warrell DA, Looareesuwan S, Phillips RE, White NJ, Warrell MJ, Chapel HM, Areekul S, Tharavanij S. Function of the blood-cerebrospinal fluid barrier in human cerebral malaria: rejection of the permeability hypothesis. Am. J. Trop. Med. Hyg. 1986;35:882-9
152. Wilhelm I, Fazakas C, Krizbai IA. In vitro models of the blood-brain barrier. Acta Neurobiol. Exp. (Wars). 2011;71:113-28
153. Woessner JF Jr. MMPs and TIMPs--an historical perspective. Mol. Biotechnol. 2002;22:33-49
154. Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 2000;14:163-76.
155. Zanini GM, Cabrales P, Barkho W, Frangos JA, Carvalho LJ. Exogenous nitric oxide decreases brain vascular inflammation, leakage and venular resistance during Plasmodium berghei ANKA infection in mice. J. Neuroinflammation. 2011;8:66
156. Zougbédé S, Miller F, Ravassard P, Rebollo A, Cicéron L, Couraud PO, Mazier D, Moreno A. Metabolic acidosis induced by Plasmodium falciparum intraerythrocytic stages alters blood-brain barrier integrity. J. Cereb. Blood Flow Metab. 2011;31:514-26